Research Misconduct in FDA-Regulated Clinical Trials: A Cross-sectional Analysis of Warning Letters and Disqualification Proceedings Article

Garmendia, Craig A, Bhansali, Neera, Madhivanan, Purnima. (2018). Research Misconduct in FDA-Regulated Clinical Trials: A Cross-sectional Analysis of Warning Letters and Disqualification Proceedings . Therapeutic Innovation and Regulatory Science, 52(5), 592-605. 10.1177/2168479017749514

cited authors

  • Garmendia, Craig A; Bhansali, Neera; Madhivanan, Purnima

sustainable development goals

authors

publication date

  • September 1, 2018

published in

keywords

  • Code of Federal Regulations
  • INVESTIGATORS
  • Life Sciences & Biomedicine
  • Medical Informatics
  • Pharmacology & Pharmacy
  • Science & Technology
  • clinical investigator
  • disqualification
  • inspection
  • regulatory action
  • warning letter

Digital Object Identifier (DOI)

start page

  • 592

end page

  • 605

volume

  • 52

issue

  • 5